What the chemoWave community is saying

“chemoWave is a fantastic tool for me since I keep track of all my wife’s meds, daily condition & symptoms. chemoWave app makes it so easy for me, my wife’s Oncologist loves it and is referring it to his patients.”

“I love chemoWave! It feels like for the first time in my journey that I understand what is going on with my body and my emotions…. [It’s] extremely easy to use, which encourages me to enter the data during the day. I also love the surveys and seeing how others are answering the same questions. It gives a great sense of community knowing that others are going through the same thing.”

“I find chemoWave helpful and easy to use. I have recommended it to a few friends too…  your app is a perfect way for me to collect information to assist my MDs and nurses.”

“I am THRILLED/LOVING this app! It is exactly what is needed! I had been sporadically adding notes to my iPhone to capture things I wanted to speak to my physician about. This is all that and more! So many meds are taken “as needed” (even non-prescription ones) that I was having a hard time remembering. I am single, therefore don’t have a caretaker, the help from chemoWave is priceless!” 

“I shared chemoWave with my oncologist who is a world-famous Dr. She said that it was “very cool.”  It is an excellent way to track days when symptoms go south. I am posting it to my Multiple Myeloma group on Facebook.”

“I love it! I like how it tracks symptoms how I feel. Needed a medicine tracker that is easier than a notebook… 3 young kids it’s so hard to jot meds down”

“My husband has Rheumatoid Arthritis so I initially downloaded chemoWave for him to track his progress. It’s fairly intuitive.  Since then, my mom has been diagnosed with lung cancer so we will be using it for her as well.”

“Thank you for creating this app. I am finished with chemo and radiation but have to take Arimidex for 5 years. This will help me track side effects to show the oncologist. I have posted a link on the breast cancer groups on face book.”